Nusep Financial Data

Nome da Companhia:Memphasys LtdStatus:Active
End of fiscal year:29 Junho 2018ISINAU000000MEM5
Year established:2006Company sector name:Healthcare
Trading currency:AUDIndustry name:Biotechnology
Place of incorporation:Austrália (AU)Industry group nameBiotechnology
Doing business in:Austrália (AU)Address30 Richmond Road
Homebush, 2140
Tel.:+61 284157300City/Country:Sydney, Austrália
Fax:+61 284157399Web address:http://www.memphasys.com.au
Descrição do Negócio:Memphasys Ltd operates as a bio-separations company in Australia. It is engaged in developing and commercializing separation techniques based on the company's proprietary membrane technology. Its technology includes SpermSep and Hydrogel polymer membrane technology development.
Price Price change [%] Bid Offer Open High Low Volume
0,015  0,001[7,14%] 0,014 0,015 0,014 0,015 0,014 335.382
Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
550.133718 0,01 - 0,08

MEM Balance Sheet Chart (-)

:assets
Período Máx. Mín.
1 Semana0,0150,013
1 Mês0,0160,013
3 Meses0,0170,012
6 Meses0,0590,012
1 Ano0,080,012
3 Anos0,160,012
5 Anos0,160,001

Share price performance previous 3 years

Share price performance intraday

Período Abe Abe Méd. VWAP diário Vol Mín. Vol Máx. Vol Méd. Var %
1 Semana0,0150,01420,01435616.2421.085.296634.9760,000,0%
1 Mês0,0130,0145670,01464316.2421.437.361593.1130,00215,38%
3 Meses0,0160,0144790,0144662.2752.638.473518.236-0,001-6,25%
6 Meses0,0430,0185650,0200942.2755.973.941674.750-0,028-65,12%
1 Ano0,0710,0380870,0364342.2755.973.941575.734-0,056-78,87%
3 Anos0,0530,0684730,0746292.27516.183.235814.109-0,038-71,7%
5 Anos0,0020,0572630,0380961.060257.859.5012.092.0590,013650,0%

MEM Growth Ratios (-)

1 year 3 years 5 years 10 years
Diluted EPS growth
-
-
-
-
Diluted continuous EPS growth
-
-
-
-
Dividend growth
-
-
-
-
Equity per share growth
-
-
-
-
Revenue growth
-
-
-
-
Operating income growth
-
-
-
-
Net income growth
-
-
-
-
Net income cont growth
-
-
-
-
CFO growth
-
-
-
-
FCF growth
-
-
-
-
Operating revenue growth
-
-
-
-

MEM Efficency Ratios (-)

Days in sales
-
Days in inventory
-
Days in payment
-
Cash conversion cycle
-
Receivable turnover
-
Inventory turnover
-
Payable turnover
-
Fixed assets turnover
-
Assets turnover
-
ROE
-
ROA
-
ROIC
-
FCF sales ratio
-
FCF net income ratio
-
Capital expenditure sales ratio
-

MEM Financial Health Ratios (-)

Current ratio
-
Quick ratio
-
Debt total capital ratio
-
Debt equity ratio
-
Financial leverage
-
Total debt to equity
-

MEM Avearge Growth Ratios Over 5 Years (-)

Growth ann capital spending
-
Growth ann gross profit
-
Avg gross margin
-
Avg post tax margin
-
Avg pre tax marginr
-
Avg net profit
-
Avg ret commonr
-
Avg ret assets
-
Avg ret invested capital
-

MEM Profitability Ratios (-)

Gross margin
-
Operating margin
-
EBT margin
-
Tax rate
-
Net margin
-
Sales per employee
-
EBIT margin
-
EBITDA margin
-
Normalized net profit margin
-
Interest coverage
-
Inc per employee tot ops
-

MEM Valuation Ratios (-)

Sales per share
-
Growth ann sales per share 5 ye...
-
Book value per share
-
CF per share
-
Price to EPS
-
Ratio PE 5 year high
-
Ratio PE 5 year low
-
Price to book
-
Price to sales
-
Price to cash flow
-
Price to free cash flow
-
Div rate
-
Dividend yield
-
Div payout tot ops
-
Div payout 5 year
-
Payout ratio
-
Sustainable growth rate
-
Cash return
-
Seu Histórico Recente
BOV
VALE5
Vale PNA
BOV
IBOV
iBovespa
BOV
PETR4
Petrobras
BOV
IGBR3
IGB SA
FX
USDBRL
Dólar EUA ..
Ações já vistas aparecerão nesta caixa, facilitando a volta para cotações pesquisadas anteriormente.

Registre-se agora para criar sua própria lista de ações customizada.

Faça o login em ADVFN
Registrar agora

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

P: V: D:20230128 22:52:26